The vesamicol receptor ligand (+)-meta-[1251]iodobenzyltrozamicol {(+)-[125¦]-MIBT} reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: Possible implications for parkinson's disease

Abstract
No abstract available